These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20513304)

  • 41. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 44. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M; Wodak A; Conigrave KM
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
    Iversen J; Topp L; Wand H; Maher L
    Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
    Drucker E; Lurie P; Wodak A; Alcabes P
    AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006
    [No Abstract]   [Full Text] [Related]  

  • 48. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
    Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
    AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essentiality of HIV testing and education for effective HIV control in the national pilot harm reduction program: the Taiwan experience.
    Lee HY; Yang YH; Yu WJ; Su LW; Lin TY; Chiu HJ; Tang HP; Lin CY; Pan RN; Li JH
    Kaohsiung J Med Sci; 2012 Feb; 28(2):79-85. PubMed ID: 22313534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.
    Sullivan LE; Metzger DS; Fudala PJ; Fiellin DA
    Addiction; 2005 Feb; 100(2):150-8. PubMed ID: 15679744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; Espínola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Needle exchange programs: an economic evaluation of a local experience.
    Gold M; Gafni A; Nelligan P; Millson P
    CMAJ; 1997 Aug; 157(3):255-62. PubMed ID: 9269195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study.
    Wammes JJ; Siregar AY; Hidayat T; Raya RP; van Crevel R; van der Ven AJ; Baltussen R
    Int J Drug Policy; 2012 Sep; 23(5):358-64. PubMed ID: 22884538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison.
    Sendziuk P
    Can Bull Med Hist; 2007; 24(1):113-29. PubMed ID: 17644934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The economics of HIV prevention strategies in NSW.
    Hales JR
    N S W Public Health Bull; 2010; 21(3-4):61-4. PubMed ID: 20513302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.